The health ministry has issued a ban
on the manufacturing and sale of two drugs- Gatifloxacin and Tegaserod.
Gatifloxacin which is an antibiotic
and Tegaserod that is used to treat irritable bowel syndrome (IBS) and
constipation are likely to cause health risks. Safer alternatives for the same
are available in the market.
Several international studies have revealed that
when compared to other antibiotics, Gatifloxacin is 17times more likely to
cause a surge in the blood sugar level (BSL) among elderly patients. The use of
Tegaserod has been associated with an increased risk of heart attack and
stroke. Therefore the health ministry decided to ban these drugs under the Drug
and Cosmetics Act.